In Conversation

Norway Pharma Report 2021
Latest Reports
Norway Pharma Report 2021
- 2021
A bastion of equality with high levels of healthcare spending, excellent research and universities, a global commitment to improving health outcomes, and a deeply entrenched digital footprint, Norway is full of potential as a life sciences investment destination. This potential, however, has largely remained untapped until now, as the country has focused on its more established oil & gas and fishing industries. Without true governmental support, the Norwegian life sciences industry has been somewhat neglected, with clinical trials numbers declining in recent years and multinational companies feeling hesitant about the market access situation for their most innovative treatments. Nevertheless,…
We use cookies to ensure that we give you the best experience on our site. For more info click here